Bill Sponsor
House Bill 941
117th Congress(2021-2022)
TRANSPLANT Act of 2021
Became Law
Became Law
Became Public Law 117-15 on May 26, 2021
Overview
Text
Introduced
Feb 8, 2021
Latest Action
May 26, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
941
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
California
Republican
Alaska
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Republican
California
Democrat
Connecticut
Democrat
Maryland
Democrat
Minnesota
Democrat
Minnesota
Republican
Minnesota
Democrat
North Carolina
Republican
North Carolina
Republican
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
House Votes (1)
Senate Votes (1)
checkPassed on April 15, 2021
Question
On Motion to Suspend the Rules and Pass
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
109
House Roll Call Votes
Summary

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Text (4)
Actions (20)
05/26/2021
Became Public Law No: 117-15.
05/26/2021
Signed by President.
05/20/2021
Presented to President.
05/18/2021
Message on Senate action sent to the House.
05/17/2021
Passed Senate without amendment by Voice Vote.
05/17/2021
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
05/17/2021
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)
05/17/2021
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)
04/19/2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
04/15/2021
Motion to reconsider laid on the table Agreed to without objection.
04/15/2021
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)
04/15/2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109).(text: 04/14/2021 CR H1752-1753)
04/15/2021
Considered as unfinished business. (consideration: CR H1829)
04/14/2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
04/14/2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 941.
04/14/2021
Considered under suspension of the rules. (consideration: CR H1752-1754)
04/14/2021
Mr. Pallone moved to suspend the rules and pass the bill.
02/09/2021
Referred to the Subcommittee on Health.
02/08/2021
Referred to the House Committee on Energy and Commerce.
02/08/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:46:49 PM